Hepatitis B virus (HBV), the prototype member of the
Hepadnaviridae, can cause chronic hepatitis, cirrhosis and ultimately hepatocellular carcinoma. HBV is currently divided into eight confirmed genotypes that differ >8% from each other at the nucleotide level: A to H (for a review, see: [
1]). In addition, a novel genotype I has been reported from South-East Asia [
2‐
5] and a candidate tenth genotype J was suggested [
6]. Most genotypes can be split into subgenotypes that differ >4% from each other, such as HBV-A1 and HBV-A2 [
7]. HBV-A2 is the most prevalent HBV variant in Western Europe and North America [
7].
HBV genotype G (HBV-G), originally described as a mutated HBV variant that emerges during chronic HBV infection [
8,
9], was recognized as a separate genotype in 2000 [
10]. HBV-G is distinct from other HBV genotypes in having a 36-nucleotide insertion at the 5′ end of the core protein gene, which adds 12 amino acids to the protein and interferes with core protein expression and virion secretion [
11‐
13]. In addition, one or two stopcodons are usually present in the precore region that preclude HBeAg expression [
10,
14]. Altogether, these characteristics hamper virus replication and make HBV-G mono-infection a rarely observed event [
14‐
16]. Apparently, HBV-G replication can be rescued by co-infection with another HBV genotype, and such dual infections have been observed repeatedly with HBV genotype A in Japan [
17,
18], the USA [
19,
20], Spain [
21] and Canada [
22], with HBV genotypes A, C or D in Germany [
23,
24], with HBV genotype H in Mexico [
25], and with HBV genotype F in Argentina [
26]. In fact, rescue by another genotype can be very effective, even to the point where HBV-G outcompetes the co-infecting strain [
9,
17,
19]. This phenomenon has also been observed in humanized mouse models [
27,
28]. Infections with HBV-G are especially prevalent in specific risk groups such as human immunodeficiency virus type 1 (HIV-1) infected men having sex with men (MSM) and intravenous drug users [
18,
21,
22,
25,
26,
29‐
31]. HBV-G strains isolated worldwide show very little genetic variation compared to other HBV genotypes [
10]. There are indications that mixed HBV infections that include an HBV-G strain are associated with increased liver fibrosis [
27,
28,
30], suggesting that patients infected with HBV-G should be monitored more closely. Also, response to antiviral treatment has been reported to be less effective in patients co-infected with HBV-G as compared to single genotype infections [
23].
The prevalence of HBV-G infections in most countries in northern Europe, including the Netherlands, is not known. Therefore, we determined the occurrence of HBV-G infections and its association with HBV-A in patients visiting our academic hospital in Amsterdam, the Netherlands during 2000-2011. HBV-A is the most prevalent, endemic HBV genotype in the Netherlands and is found especially among MSM [
32]. In addition, we determined the longitudinal plasma viral load (pVL) changes of HBV in genotypes A and G in three dually infected patients. The complete genomes of three HBV genotype G strains were sequenced to analyse their genetic relatedness to genotype G strains isolated in other countries worldwide.